Overview
Neuroendocrine neoplasms of the lung encompass a spectrum of tumors including carcinoid tumors and small cell lung carcinomas, characterized by the presence of neuroendocrine differentiation and secretory granules. 1Diagnosis
Immunohistochemical markers: Use neuron-specific enolase (NSE), bombesin (Bn), and chromogranin (Cg) for diagnosis.
NSE: Present in all neuroendocrine granule-bearing tumors but also in 57% of non-neuroendocrine carcinomas.
Bombesin: Highly specific for neuroendocrine tumors, present in 68% of neuroendocrine tumors but rare in non-neuroendocrine tumors.
Chromogranin: Correlates with density of neuroendocrine granules; useful but absent in small cell anaplastic carcinomas.
Electron microscopy: Can assess density of neurosecretory granules for further differentiation.
Panel of antibodies: Consider using multiple markers for reliable identification.
Correlation with granules: Evaluate cytoplasmic density of neurosecretory granules for enhanced diagnostic accuracy. 1Management
First-line treatment: Specific drug classes and doses not detailed in provided abstracts.
Chemotherapy: Often used in small cell lung cancer; specific regimens not specified here.
Targeted therapies: Not addressed in the given abstracts.
Surgical resection: Recommended for localized disease, particularly in well-differentiated neuroendocrine tumors.
Radiation therapy: Utilized in specific cases, particularly for unresectable or metastatic disease.
Supportive care: Essential for symptom management and quality of life improvement.
Hormonal manipulation: Considered in specific cases based on tumor biology, though specific agents not detailed. 1Special Populations
Pregnancy: Management considerations not addressed in provided abstracts.
Pediatrics: No specific data provided in the abstracts.
Elderly: Tailored treatment approaches based on comorbidities and functional status are recommended but specifics are not detailed.
Comorbidities: Management should consider interaction with existing conditions, though specific guidance is not provided. 1Key Recommendations
Utilize a panel of immunohistochemical markers including NSE, bombesin, and chromogranin for accurate diagnosis of neuroendocrine lung tumors. (Evidence: Moderate) 1
Consider the density of neurosecretory granules via electron microscopy to aid in distinguishing between different neuroendocrine lung tumor types. (Evidence: Moderate) 1
Employ surgical resection for localized well-differentiated neuroendocrine tumors when feasible. (Evidence: Expert opinion) 1References
1 Said JW, Vimadalal S, Nash G, Shintaku IP, Heusser RC, Sassoon AF et al.. Immunoreactive neuron-specific enolase, bombesin, and chromogranin as markers for neuroendocrine lung tumors. Human pathology 1985. link80008-3)